Rezension:
What do you do? buy durexo Brokerage Barclays Capital upgraded the IT servicesprovider\'s stock to \"overweight\" from \"equal weight\" as it seesgrowth in the company\'s business in consulting and outsourcingin Europe. It also expects strong growth in its health carebusiness. Barclays raised its price target on the company\'sstock to $97 from $80. Brokerage Evercore Partners also raisedits price target late on Tuesday.
